The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin

Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin

(2011) Jun-Shik Choi et al.   ARCHIVES OF PHARMACAL RESEARCH

Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin

(2010) Jyoti Choubey et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Pharmacokinetic Modeling of Doxorubicin Pharmacokinetics in Dogs Deficient in ABCB1 Drug Transporters

(2010) D.L. Gustafson et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol

(2010) In-Soo Yoon et al.   XENOBIOTICA

Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats

(2008) Tripta Bansal et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats

(2008) D. R. Kalaria et al.   PHARMACEUTICAL RESEARCH

Enhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery System

(2007) Weilun Ke et al.   JOURNAL OF PHARMACEUTICAL SCIENCES